Deep Brain Stimulation Devices - Global Strategic Business Report 2015-2020: Questions Arise on the Current Pace of Innovation

Aug 18, 2015, 08:10 ET from Research and Markets

DUBLIN, Aug. 18, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/2tpvn7/deep_brain) has announced the addition of the "Deep Brain Stimulation Devices - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Deep Brain Stimulation Devices in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 14 companies including many key and niche players such as

  • Aleva Neurotherapeutics SA (Switzerland)
  • Boston Scientific Corp. (US)
  • Deep Brain Innovations, LLC (US)
  • Medtronic, plc (US)
  • St. Jude Medical, Inc. (US)

Key Topics Covered:

1. INDUSTRY OVERVIEW

2. MARKET DYNAMICS

3. TARGETED INDICATIONS FOR DBS

4. COMPETITIVE LANDSCAPE

5. PRODUCT OVERVIEW

6. PRODUCT APPROVALS/INTRODUCTIONS

7. RECENT INDUSTRY ACTIVITY

8. FOCUS ON SELECT PLAYERS

9. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 14 (including Divisions/Subsidiaries - 15)

  • The United States (8)
  • Canada (1)
  • Europe (5)
  • - France (1)
  • - Germany (2)
  • - Rest of Europe (2)
  • Asia-Pacific (Excluding Japan) (1)

For more information visit http://www.researchandmarkets.com/research/2tpvn7/deep_brain

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com